In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Pils, Marina C
MetadataShow full item record
AbstractPatients suffering from cystic fibrosis (CF) are commonly affected by chronic Pseudomonas aeruginosa biofilm infections. This is the main cause for the high disease severity. In this study, we demonstrate that P. aeruginosa is able to efficiently colonize murine solid tumors after intravenous injection and to form biofilms in this tissue. Biofilm formation was evident by electron microscopy. Such structures could not be observed with transposon mutants, which were defective in biofilm formation. Comparative transcriptional profiling of P. aeruginosa indicated physiological similarity of the bacteria in the murine tumor model and the CF lung. The efficacy of currently available antibiotics for treatment of P. aeruginosa-infected CF lungs, such as ciprofloxacin, colistin, and tobramycin, could be tested in the tumor model. We found that clinically recommended doses of these antibiotics were unable to eliminate wild-type P. aeruginosa PA14 while being effective against biofilm-defective mutants. However, colistin-tobramycin combination therapy significantly reduced the number of P. aeruginosa PA14 cells in tumors at lower concentrations. Hence, we present a versatile experimental system that is providing a platform to test approved and newly developed antibiofilm compounds.
CitationIn Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa. 2015, 59 (8):4974-81 Antimicrob. Agents Chemother.
AffiliationMolecular Bacteriology, Twincore, Centre for Clinical and Experimental Infection Research, Hannover, Germany.
The following license files are associated with this item:
- In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
- Authors: Fernández-Olmos A, García-Castillo M, Maiz L, Lamas A, Baquero F, Cantón R
- Issue date: 2012 Aug
- Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
- Authors: Herrmann G, Yang L, Wu H, Song Z, Wang H, Høiby N, Ulrich M, Molin S, Riethmüller J, Döring G
- Issue date: 2010 Nov 15
- Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
- Authors: Furiga A, Lajoie B, El Hage S, Baziard G, Roques C
- Issue date: 2015 Dec 28
- Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
- Authors: Price KE, Orazi G, Ruoff KL, Hebert WP, O'Toole GA, Mastoridis P
- Issue date: 2015
- In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.
- Authors: Hengzhuang W, Wu H, Ciofu O, Song Z, Høiby N
- Issue date: 2012 May